CHIMERIX INC. - COMMON STOCK

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

02 Jul 2024 10:41:23 By NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

01 Jul 2024 16:14:17 By NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

18 Jun 2024 16:05:58 By NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

14 Jun 2024 16:05:40 By NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

13 Jun 2024 16:15:10 By NetDania Notify

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

30 May 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

01 May 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

24 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Chimerix Appoints Marc D. Kozin to Board of Directors

21 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Present at TD Cowen 44th Annual Health Care Conference

27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Appoints Lisa Decker to Board of Directors

29 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

24 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

16 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update

02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"

16 Aug 2023 10:05:00 By Nasdaq GlobeNewswire